An interventional study of WOW Intervention in Pre-hypertension and Hypertension, sponsored by Johns Hopkins University. Withdrawn at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-03-22.
Sponsored by Johns Hopkins University · Not applicable, Interventional, and Prevention
Among 82 studies in Prehypertension with a site in United States — 6 open to participants now, 7 under way, 1 of them phase 3. Prehypertension · United States.
Among the 82 studies in Prehypertension with a site in United States, this one is the 75th largest by enrollment of the 76 interventional ones that give a count, is one of 2 that started in 2023, is one of 54 with no phase, and was the 66th registered.
158 studies on the registry are indexed under Prehypertension; 21 are open to participants now.
Browse Prehypertension studies →6 of the 82 studies in Prehypertension with a site in United States are open now. Recruiting first, the newest first:
Eli Lilly and Company · Sites in United States, Argentina, China and 9 more countries
University of Hartford · Sites in United States
Duke University · Sites in United States
Duke University · Sites in United States
Emory University · Sites in United States
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 11 Prehypertension studies recruiting now, 3 (27%) set no upper age limit and 7 (64%) stop at 75 or younger; 3 take children under 18; 6 take healthy volunteers.
This study: 18 Years and older · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
82 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 5 · Phase 2 12 · Phase 3 2 · Phase 4 8
First in 2004; this study’s year is marked. 2 started in 2023.
Median enrollment 60 across the 76 interventional studies, 130 across the 6 observational. Of the 66 that completed or were terminated, 13 (20%) have results posted.
This tab as a report to print or save as PDF → With an account.
8 of 82 have an industry lead sponsor. The 10 most frequent:
Johns Hopkins University is the lead sponsor of 1,815 studies on the registry; 315 are open to participants now.
Of its 208 completed or terminated interventional studies of FDA-regulated products, 144 (69%) have results posted.
Johns Hopkins University has 4 studies filed under Prehypertension — fewer than ten, so there is no comparison to draw.
2 of the studies in Prehypertension with a site in United States that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07453550University of HartfordThe Effects of Brief Periods of Exercise on Blood Pressure | 2026-12 |
| NCT06595251Duke UniversityCommunity Park-Based Programs for Health Promotion: Fit2Play Prospective Cohort Study | 2027-05-17 |
Among the 82 studies in Prehypertension with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The Wald Outreach Center will partner with Medicine for the Greater Good (MGG) to implement this pilot project called Wald Outreach for Wellness (WOW), a blood pressure outreach wellness intervention in a retail setting.
WOW aims to provide community members with a digital blood pressure monitor, health education, and health care navigation as practical strategies to improve community members' management of pre-hypertension, and to reduce associated burdens and risks related to hypertension health disparities.
This approach to reaching populations who use retail settings has the potential to implement a health promotion and wellness strategy aimed at populations with increased risk for hypertension related health disparities. The outreach strategy is aimed at reaching community members where community members gather for health care, provide the community members with practical, low-cost strategies for promoting health and wellness, increase community members' knowledge in hypertension management, help the community members navigate health care options and get the community members engaged in a medical home thereby reducing the burdens of hypertension health disparities.
This research is important to continue to assess the best ways to reach and reduce hypertension health disparities in underserved communities with limited access to health care.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Participants will receive blood pressure monitor and health passport to record blood pressure readings for 3 months. Participants will receive daily text message reminders to take and record blood pressure readings. Participants will receive health education and health care navigation. Participants will be assessed for social determinants of health. Participants will take surveys 3 times over 3 months. Participants will receive home visits or phone calls to collect data and receive health coaching.
Behavioral: WOW Intervention
Health education and coaching, health care navigation,
Change in actions to control hypertension as assessed by the Behavioral Risk Factor Surveillance System Module 7
Change in yes/no answers assessed by Behavioral Risk Factor Surveillance System (BRFSS) Module 7. 10 questions graded by yes/no response.
Time frame: Assessed at baseline, 6 weeks and 12 weeks
Change in blood pressure
Change in blood pressure (BP) measured in mmHg.
Time frame: Assessed at baseline and every 2 weeks, up to 3 months
Change in usage of BP monitor
Change in usage of blood pressure monitor assessed by number of BP readings done by participants.
Time frame: Assessed at baseline and every 2 weeks, up to 3 months
Change in knowledge of the signs and symptoms of a heart attack and stroke as assessed by BRFSS Module 8
Change in knowledge (yes/no responses) of signs and symptoms of stroke/heart attack as assessed by BRFSS Module 8. 13 Questions graded by yes/no.
Time frame: Assessed at baseline, 6 weeks and 12 weeks
Change in engagement with healthcare provider as assessed by BRFSS Section 3
Change in engagement with healthcare provider/medical home as assessed by BRFSS Section 3. 3 questions graded by yes/no.
Time frame: Assessed at baseline, 6 weeks and 12 weeks
Plan to share: No
No publications or documents are linked to this record.
Start is estimated for Feb 2023; primary completion for Feb 2024, 12 months later.
How these figures are worked out, and which studies are left out of them.
This study is withdrawn, as verified in Aug 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.